全民健康覆盖(UHC)
Search documents
柬卫生部推介第四版新生殖健康国家战略
Shang Wu Bu Wang Zhan· 2025-11-20 12:30
自内战结束和国家走向复苏以来,柬埔寨经济社会和人口结构经历了重大变化和发展,特别是在孕产妇 和新生儿健康指标方面取得了显著进展。其中,孕产妇死亡率从1990年曾每10万活产1020例死亡,大幅 下降至2000年每10万活产488例,2016年进一步降至168例,惟2021年却上升至189例。在新战略下,卫 生部定下于2030年实现每10万活产少于70死亡病例的宏伟目标。与此同时,由熟练助产士接生比例,也 从2000年的32%激增至2021年的89%。柬埔寨总生育率则稳步下降,从2000年每名妇女生育3.8个孩 子,降至目前的2.7个。 当前,青少年女孩意外怀孕和堕胎问题已成为一个重大的公共卫生问题,带来严重的个人、社会和经济 影响。根据2010年至2014年的数据显示,15至19岁女性的青少年生育率出现令人担忧的增长,从8%上 升到12%,其中增幅最大的是未受教育的年轻女性。 此外,城市化发展和人口流动也带来了新的挑战。有关当局调查发现,2010年至2014年间金边堕胎率增 加,归因于年轻女性流动工人的涌入,这创造了一个新的弱势群体。调查称,这些女性通常居住在近郊 地区,获得持续现代避孕药具的机会有限,加上与 ...
菲医药市场规模今年预计达20亿美元 UHC推动仿制药市场增长
Shang Wu Bu Wang Zhan· 2025-09-24 17:10
Core Insights - The Philippine pharmaceutical market is projected to generate $2 billion in revenue this year, driven by the demand for generic drugs and the implementation of Universal Health Coverage (UHC) [2] - The market is expected to grow at a stable rate of 4.1% annually until 2029 [2] Industry Overview - The Philippine pharmaceutical industry remains reliant on imports, with a steady increase in drug imports from 2019 to 2024, while exports have been declining [2] - In the first half of 2025, exports decreased by 25%, whereas imports grew by 5% [2] Strategic Initiatives - The Philippine Board of Investments (BoI) has implemented a comprehensive roadmap for the pharmaceutical industry (IRPPI) since 2023, which includes the release of guidelines for pharmaceutical economic zones and the simplification of export processes [2] - Plans are underway to establish a Philippine Virology Research Institute, aimed at enhancing the flexibility and resilience of the industry’s value chain [2] - The goal is to increase domestic manufacturers' capacity to produce registered drugs to 60%, positioning the Philippines as a major producer of essential medicines and services [2]